Figure 2.
Clinical course of the patient. Forty-five days after ATG initiation, the serum LDH level was elevated to more than 3,000 U/L, and the serum EBV-DNA level increased to 1.1×106 copies/106 cells. Following rituximab therapy, these levels rapidly decreased. Rituximab was administered once a week for 8 weeks.